These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 16195368)

  • 1. Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs.
    Townsend KP; Praticò D
    FASEB J; 2005 Oct; 19(12):1592-601. PubMed ID: 16195368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action.
    Gasparini L; Ongini E; Wenk G
    J Neurochem; 2004 Nov; 91(3):521-36. PubMed ID: 15485484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.
    Heneka MT; Sastre M; Dumitrescu-Ozimek L; Hanke A; Dewachter I; Kuiperi C; O'Banion K; Klockgether T; Van Leuven F; Landreth GE
    Brain; 2005 Jun; 128(Pt 6):1442-53. PubMed ID: 15817521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease.
    Gasparini L; Ongini E; Wilcock D; Morgan D
    Brain Res Brain Res Rev; 2005 Apr; 48(2):400-8. PubMed ID: 15850679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coxibs and Alzheimer's disease: should they stay or should they go?
    Firuzi O; Praticò D
    Ann Neurol; 2006 Feb; 59(2):219-28. PubMed ID: 16402383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental brain inflammation and neurodegeneration as model of Alzheimer's disease: protective effects of selective COX-2 inhibitors.
    Giovannini MG; Scali C; Prosperi C; Bellucci A; Pepeu G; Casamenti F
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):31-40. PubMed ID: 14552702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear receptor peroxisome proliferator-activated receptor-gamma is activated in rat microglial cells by the anti-inflammatory drug HCT1026, a derivative of flurbiprofen.
    Bernardo A; Ajmone-Cat MA; Gasparini L; Ongini E; Minghetti L
    J Neurochem; 2005 Feb; 92(4):895-903. PubMed ID: 15686492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No improvement after chronic ibuprofen treatment in the 5XFAD mouse model of Alzheimer's disease.
    Hillmann A; Hahn S; Schilling S; Hoffmann T; Demuth HU; Bulic B; Schneider-Axmann T; Bayer TA; Weggen S; Wirths O
    Neurobiol Aging; 2012 Apr; 33(4):833.e39-50. PubMed ID: 21943956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.
    Hirohata M; Ono K; Naiki H; Yamada M
    Neuropharmacology; 2005 Dec; 49(7):1088-99. PubMed ID: 16125740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia.
    Pasinetti GM
    J Alzheimers Dis; 2002 Oct; 4(5):435-45. PubMed ID: 12446975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation, and pathology.
    van Groen T; Miettinen P; Kadish I
    J Alzheimers Dis; 2011; 24(2):301-13. PubMed ID: 21239852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The possible suppression of Alzheimer's disease by nonsteroidal anti-inflammatory drugs].
    de Jong D; Jansen RW; Verbeek MM; Kremer HP
    Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2074-8. PubMed ID: 12448960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity.
    Weggen S; Eriksen JL; Das P; Sagi SA; Wang R; Pietrzik CU; Findlay KA; Smith TE; Murphy MP; Bulter T; Kang DE; Marquez-Sterling N; Golde TE; Koo EH
    Nature; 2001 Nov; 414(6860):212-6. PubMed ID: 11700559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of nuclear factor-kappa B activity by indomethacin influences A beta levels but not A beta precursor protein metabolism in a model of Alzheimer's disease.
    Sung S; Yang H; Uryu K; Lee EB; Zhao L; Shineman D; Trojanowski JQ; Lee VM; Praticò D
    Am J Pathol; 2004 Dec; 165(6):2197-206. PubMed ID: 15579461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of inflammation in Alzheimer's disease.
    Tuppo EE; Arias HR
    Int J Biochem Cell Biol; 2005 Feb; 37(2):289-305. PubMed ID: 15474976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions.
    Pasinetti GM
    J Neurosci Res; 1998 Oct; 54(1):1-6. PubMed ID: 9778144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of non-steroidal anti-inflammatory drugs on Abeta deposition in Abeta(1-42) transgenic C. elegans.
    Morita M; Osoda K; Yamazaki M; Shirai F; Matsuoka N; Arakawa H; Nishimura S
    Brain Res; 2009 Oct; 1295():186-91. PubMed ID: 19666013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology.
    van Groen T; Kadish I
    Brain Res Brain Res Rev; 2005 Apr; 48(2):370-8. PubMed ID: 15850676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease.
    Imbimbo BP
    Expert Opin Investig Drugs; 2009 Aug; 18(8):1147-68. PubMed ID: 19589092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.